Multiple disciplinary team management of rare primary splenic malignancy:Two case reports  

作　　者：Hao Luo Tao Wang Le Xiao Chao Wang Hai Yi 

机构地区：[1]Department of General Surgery Center,General Hospital of Western Theater,Chengdu 610083,Sichuan Province,China [2]Department of Pathology,General Hospital of Western Theater,Chengdu 610083,Sichuan Province,China [3]Department of Hematology,General Hospital of Western Theater,Chengdu 610083,Sichuan Province,China

出　　处：《World Journal of Clinical Cases》2022年第29期10535-10542,共8页世界临床病例杂志

基　　金：Supported by the NSFC,No.81502696;Technology Plan Program of Sichuan Province,No.2018JY0185;Program of General Hospital of Western Theater,No.2021-XZYG-C3;Science&Technology Department of Sichuan Province International Cooperation Program,No.2019YFH0056 and 2020YFSY0022。

摘　　要：BACKGROUND Malignant splenic tumors are rare but fatal,presenting a challenge in diagnosis and management involving hematology,oncology,and general surgery.By contrast,diagnosing and treating other common malignant tumors(such as lung and gastrointestinal cancer)offers multiple strategies for chemotherapy,radiotherapy,targeted therapy,and immunotherapy with the prospect of a cure.With various specialists involved in clinical multiple disciplinary team(MDT)discussion,personal bias can be minimized.It can also ignite important discussion which can benefit not only one patient but many patients.CASE SUMMARY Here,we report on the MDT diagnosis and management of the malignant splenic tumors littoral cell angiosarcoma and histiocytic sarcoma.Although only two cases of rare primary splenic malignancy are presented,MDT is a novel means of rare disease treatment.CONCLUSION To benefit patients,imaging analysis,safe operation,precise pathology examination,and individualized therapeutic treatment strategies are required.The involvement of various specialists in a clinical MDT discussion minimizes personal bias and can create important ideas to benefit all patients.

关 键 词：Multiple disciplinary team Splenic malignancy Littoral cell angiosarcoma Histiocytic sarcoma Case report 

分 类 号：R733.2[医药卫生—肿瘤]